Ciprofloxacin ophthalmic ointment
Alternative Names: Ciloxan OintmentLatest Information Update: 04 Dec 2021
At a glance
- Originator Alcon; Bayer
- Class Anti-infectives; Antibacterials; Carboxylic acids; Cyclopropanes; Fluoroquinolones; Piperazines; Small molecules
- Mechanism of Action Type II DNA topoisomerase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Corneal ulcer; Infectious conjunctivitis
Most Recent Events
- 09 Apr 2019 Novartis completed the spin-off of Alcon eye care devices business
- 26 Aug 2010 Alcon has been acquired by Novartis
- 26 Jan 2006 Launched for Conjunctivitis in United Kingdom (Ophthalmic)